Tag Archive | Linagliptin

Linagliptin Introduction

Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor which is acclimated in aggregate with diet and exercise in the analysis of blazon 2 diabetes, either abandoned or in aggregate with added articulate hypoglycemic agents. Linagliptin is a almost new medication and has yet to be active in causing clinically credible alarmist injury. In ample analytic trials, […]

Linagliptin Chemical Properties,Usage

CAS:668270-12-0 Molecular formula:C25H28N8O2 Molecular weight:472.54 Density:  1.39 Melting point:  202 ºC Appearence:  White Usage: A novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Product description:Linagliptin (BI-1356, trade names Tradjenta and Trajenta) is a DPP-4 inhibitor developed by Boehringer Ingelheim for treatment of type II diabetes. […]